Watch: New Cancer Drugs from Artificial Life

In 2014 artificial life was made for the first time.

Two new nucleotides were added—X and Y—to the standard four: A, G, T, C

These new nucleotides allow for the addition of unnatural amino acids to create entirely new kinds of proteins.

Now biotech company Synthorx has announced that they have developed a new cancer drug using these artificial bacteria.

Interleukin-2 has been studied for decades as an immune system-stimulating cancer therapy, but it unfortunately comes with some serious side effects and is often unpredictable.

By adding an extra unnatural amino acid to Interleukin, Synthorx created a “Synthorin” that prolongs the protein’s activity while eliminating its immune-suppressing effects.

So, it turns out that creating artificial life is more than a cool laboratory trick—it may turn out to be a great new way to create new drugs as well.

http://www.sandiegouniontribune.com/business/biotech/sd-me-synthorx-cancer-20180430-story.html

Follow us on social media for the latest updates in B2B!

Image

Latest

automation
Episode 2 Promo: How Vecna Robotics Keeps Automation Aligned with the Floor
May 10, 2025

The second episode of Robot vs. Wild features David Rabinovic, Vice President of Deployment at Vecna Robotics, and Josh Kivenko, Chief Marketing Officer, in a conversation about the ever-changing nature of warehouse environments and what it takes to keep automation aligned with reality. Unlike manufacturing, where operations follow predictable cycles, warehouses are dynamic ecosystems—shifting every…

Read More
Robotics
Episode 3 Promo: Inside Vecna Robotics’ Mission to Build Safer Automated Warehouses
May 9, 2025

The third episode of Robot vs. Wild takes a close look at one of the most critical success factors in automation: robot safety. Featuring Michael Bearman, Chief Legal & Safety Officer, and Josh Kivenko, Chief Marketing Officer at Vecna Robotics, this episode explores why safety in automation isn’t just about the robots—it’s about people, processes,…

Read More
Vecna Robotics
Episode 4 Promo: How Vecna Robotics Connects Tech and Strategy for Smarter Automation
May 9, 2025

Episode four of Robot vs. Wild features a conversation between Zachary Dydek, Chief Technology Officer at Vecna Robotics, and Josh Kivenko, the company’s Chief Marketing Officer. The episode explores the advanced technologies behind Vecna’s automation solutions and how engineering and marketing align to deliver scalable, human-centered innovation. Topics include real-time orchestration, autonomous systems, and how…

Read More
automation
Episode 5 Promo: There Are No Bad Robots, Only Bad Owners
May 9, 2025

What really makes or breaks a robotics deployment? Spoiler: it’s not the robot. In the fifth episode of Robot vs. Wild, Vecna Robotics’ Chief Marketing Officer Josh Kivenko and Customer Success Manager Ty LaFramboise reveal why successful automation is less about machines—and more about mindset. From aligning corporate goals with floor-level operations, to helping teams adjust to new…

Read More